Zhang Jingyu, Zhan Yinxia, Chen Jiaojiao, Kang Dan, Xiang Rumei, Zhang Ruoyi, Zhang Yubo, Pu Yang, Zhang Jiayuan, Zhang Lijun, Huang Yanyan, Gong Ruoyan, Su Xueyao, Nie Yuxian, Shi Qiuling
State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, People's Republic of China.
School of Public Health, Chongqing Medical University, Chongqing, People's Republic of China.
Patient Prefer Adherence. 2023 Jan 19;17:199-207. doi: 10.2147/PPA.S398666. eCollection 2023.
Patients with hepatobiliary or pancreatic cancers often experience severe symptoms, resulting in a sharp decline in functioning, poor quality of life, and increased mortality risk. Early and effective management of symptoms allows a better quality of life and reduced mortality, depending on the selection of appropriate assessment of specific symptoms for a defined purpose. We aimed to develop a symptom measurement item bank for hepatobiliary or pancreatic cancers.
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement was applied to organize this systematic review. The articles validated patient-reported outcome measures (PROMs) for hepatobiliary or pancreatic cancer and published before December 2021 were retrieved from the Web of Science, PubMed, Embase databases and Cochrane Library. Items from the existing PROMs were selected and classified into different patient-reported symptoms based on the concepts and specific underlying constructs of the objects measured.
Sixteen unique PROMs were identified across the 29 eligible studies included in our analysis. Items from the literature review (14 PROMs with 421 items for which information was obtained) were selected and classified. As a result of this study, we developed a symptom item bank with 40 patient-reported symptoms and 229 assessment items for hepatobiliary or pancreatic cancer, and fatigue, pain and nausea were the most common symptom items.
We developed an item bank to assess the patient-reported symptoms of hepatobiliary or pancreatic cancer. This item bank could allow researchers to select appropriate measures of symptom and provide a basis for the development of a single-item symptom-measurement system.
肝胆或胰腺癌患者常出现严重症状,导致功能急剧下降、生活质量差及死亡风险增加。根据针对特定目的选择合适的特定症状评估方法,早期有效管理症状可提高生活质量并降低死亡率。我们旨在开发一个用于肝胆或胰腺癌的症状测量项目库。
应用系统评价和Meta分析的首选报告项目(PRISMA)声明来组织这项系统评价。从Web of Science、PubMed、Embase数据库和Cochrane图书馆检索2021年12月之前发表的、验证用于肝胆或胰腺癌的患者报告结局测量(PROMs)的文章。根据所测量对象的概念和具体潜在结构,从现有的PROMs中选择项目并分类为不同的患者报告症状。
在我们分析纳入的29项合格研究中,共识别出16个独特的PROMs。对文献综述中的项目(14个PROMs,共获得421个项目的信息)进行了选择和分类。通过本研究,我们开发了一个用于肝胆或胰腺癌的症状项目库,包含40个患者报告症状和229个评估项目,其中疲劳、疼痛和恶心是最常见的症状项目。
我们开发了一个项目库来评估肝胆或胰腺癌患者报告的症状。该项目库可使研究人员选择合适的症状测量方法,并为单项症状测量系统的开发提供基础。